Looking for a kick ass rate of return today? Well it’s too late to hop on the gravy train known as ARCA biopharma Inc (ABIO).
The stock is up 230% after the US Patent Office approved an ARCA patent attributed to treating heart failure.
Join the conversation about this story »
See Also:
- Zicam Disaster: Turns Out Snorting Cold Medicine Is A Bad Idea
- The Oink Didn’t Scare People Out Of Eating Pork
- Swine Flu Explodes In Latin America